The Powerbeats Pro 2 put fitness first, with a secure, comfortable fit and the addition of a heart rate monitor. There are some small hiccups in the sound department, but very solid battery life and a ...
Welcome to the Align fourth quarter and full-year 2024 earnings call. At this time, all participants are in a listen-only ...
Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...
Thank you for standing by and welcome to Prestige Consumer Healthcare third quarter ... After the speaker presentation, there will be a question-and-answer session to ask a question.
Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Free Report)’s share price reached a new 52-week high on Friday after the company announced better than expected quarterly earnings.
TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Prestige Consumer Healthcare Inc. (PBH) on Thursday reported fiscal third-quarter net income of $61 million. On a per-share basis, the Tarrytown ...
(RTTNews) - Prestige Consumer Healthcare Inc. (PBH) revealed earnings for its third quarter that increased from the same period last year and beat the Street estimates. The company's bottom line ...
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ...
(RTTNews) - Prestige Consumer Healthcare Inc. (PBH), Thursday announced a revised financial outlook for the fiscal year 2025, primarily due to its strong sales performance and lower interest expenses.
Prestige Consumer Healthcare Inc. beats earnings expectations ... year outlook and then take questions from analysts. A slide presentation that accompanies today’s call can be accessed by ...
For FY2025, Prestige Consumer Healthcare projects revenues between $1.128 billion and $1.132 billion, maintaining an organic growth forecast of approximately 1% versus FY2024. Adjusted EPS ...